Next Article in Journal
Bee Pollen as a Dietary Mineral Source: In Vitro Bioaccessibility and Health Risk Evaluation
Previous Article in Journal
A Novel Approach to the Design of a Solid Bismuth Microelectrode Array: Applications in the Anodic Stripping Voltammetry of Cd(II) and Pb(II)
Previous Article in Special Issue
Tyrosinase Inhibitors Among Flora of Lubelskie Region—Application of Bio-Chromatographic Approach and Zebrafish Model in Bioactivity Screening of Plant Material
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications

1
Department of Analytical Chemistry, Medical University of Lublin, Chodźki 4a, 20-093 Lublin, Poland
2
Chair and Department of Vascular Surgery and Angiology, Medical University of Lublin, 11 Staszica St., 20-081 Lublin, Poland
3
Department of Pharmaceutical Botany and Pharmacognosy, Ludwik Rydygier Collegium Medicum, Nicolaus Copernicus University, 9 Marie Curie-Skłodowska Street, 85-094 Bydgoszcz, Poland
*
Author to whom correspondence should be addressed.
Molecules 2025, 30(13), 2744; https://doi.org/10.3390/molecules30132744
Submission received: 2 June 2025 / Revised: 23 June 2025 / Accepted: 25 June 2025 / Published: 26 June 2025

Abstract

Hamamelis virginiana L. (witch hazel) is a traditionally used medicinal plant, well-known for its dermatological applications. The plant’s bark and leaves contain a rich array of bioactive compounds, including phenolic acids, flavonoids, catechins, proanthocyanidins, and tannins, many of which exhibit antimicrobial, anti-inflammatory, antioxidant, and wound-healing properties. These activities have been verified by numerous in vitro and in vivo studies, as well as limited clinical trials. The H. virginiana extracts have demonstrated effectiveness against bacteria, fungi, and some viruses. Moreover, the extracts exert anti-inflammatory effects by modulating cytokine expression and NF-κB signaling, improve skin regeneration, and protect against UV-induced damage and pollution. This review highlights H. virginiana as a complex botanical resource to be used in dermatology and cosmetology and shows that current research offers encouraging results for its future therapeutic use, especially in skin treatment.

1. Introduction

Hamamelis virginiana L. is a plant from the Hamamelidaceae family, which has been highly valued for years in both medicine and cosmetology. It is native to North America, where it is found along coastal regions, with its primary natural range stretching from southern Canada to the state of Virginia [1]. H. virginiana was well known to the native people of North America, who appreciated its medicinal properties [2]. It is commonly known as hamamelis, beadwood, and witch hazel, names which come from indigenous traditions and the plant’s unique seed dispersal mechanism—its ripe fruit capsule opens and shoots seeds at a distance of several meters [3,4].
The leaves and bark of H. virginiana have been historically utilized in folk medicine, herbal therapy, and skincare, particularly by Native American communities. Witch hazel extracts are attributed with properties that may help in curing conditions such as psoriasis, eczema, and skin dehydration, as well as easing insect bites, reactions to poison ivy (Toxicodendron radicans), and razor burn [2,5]. Additionally, witch hazel has been used for various skin conditions in many European countries, including Poland and Ukraine [6], as well as in the South Balkan and East Mediterranean Region [7,8].
Currently, H. viriniana is usually used in medicinal and cosmetic applications. The U.S. Food and Drug Administration (FDA) has approved witch hazel for inclusion in over-the-counter (OTC) formulations. Witch hazel, due to its soothing properties, is a common ingredient in OTC treatments aimed to relieve hemorrhoidal symptoms and vaginal irritations. Furthermore, it has been observed that formulations containing witch hazel extracts have a positive effect on blood vessels and enhance tissue perfusion [9,10]. Witch hazel extracts are widely used in cosmetic products for skincare. They are incorporated into anti-aging creams and gels as well as in cosmetics designed to soothe sunburn-related irritation [11,12,13,14,15]. H. virginiana, due to its soothing, anti-inflammatory, and antibacterial properties, is commonly used in products designed to address the irritation of the scalp, including hair tonic and shampoo. It helps reduce sebum production, accelerates the healing of minor wounds, and promotes tissue regeneration [16,17]. For analogous reasons, and due to its non-toxic nature [18], witch hazel is also incorporated into oral hygiene products, including various mouthwashes, toothpastes, and regenerative lip balm [19,20,21]. H. virginiana is also applied in wound care management [22].
The primary medicinal raw material obtained from H. virginiana is its leaves (Hamamelidis folium)—dried, whole, or crushed, containing 3–10% of tannin. In addition to the leaves, the bark of H. virginiana (8–12% tannins)—referred to as Hamamelidis cortex—is also widely used. Both Hamamelidis folium and Hamamelidis cortex are official herbal drugs listed in the European Pharmacopoeia. Key constituents of the Hamamelis plant include ellagitannins, hamamelitannins, flavonoids, gallic and ellagic acids, leucoanthocyanidins, and saponins. These compounds are believed to play a significant role in the cosmetic and medicinal properties of witch hazel preparations.
Despite its long-standing use and popularity in various therapeutic and cosmetic formulations, robust clinical data supporting its efficacy remain limited. Therefore, the aim of this review is to assess the current state of knowledge regarding H. virginiana, with a particular focus on its pharmacological potential in cosmetology. This is to help identify gaps in existing research and highlight the future directions of investigation to validate H. virginiana’s medicinal and cosmetic potential.
A literature survey was conducted using the Scopus, PubMed, ScienceDirect, Web of Science, Springer, and Google Scholar databases. The following keywords were used in the search: “Hamamelis virginiana” or “witch hazel”, combined with “skin”, “fibroblast”, “keratinocytes”, “melanocytes”, “antibacterial”, “anti-inflammatory”, “wound healing”, and “anti-aging”. The initial search results were screened by reviewing titles and abstracts for relevance. Full-text articles were then assessed to determine their suitability for inclusion. Studies in which the activity described was not related to dermal application or where the full text was not available in English were excluded from the review. The search period covered the years from 1990 to 2025.

2. Botanical and Phytochemical Characterization of Hamamelis virginiana

2.1. Botanical Characteristic

H. virginiana is a deciduous shrub or tree that typically reaches heights of up to 6 m (Figure 1).
The plant exhibits significant morphological variability depending on the cultivation area. It often forms dense, multi-stemmed clusters growing from its base. The bark is light brown, smooth, and scaly, with the inner bark displaying a reddish shade.
The leaves are oval, measuring 3.7–16.7 cm in length and 2.5–13 cm in width, and exhibit an asymmetrical base and a rounded or acute apex, with margins that are wavy-toothed. The petiole is short and stout, measuring 6–15 mm in length. The midrib is more or less hairy, with 6–7 pairs of primary veins. Mature leaves develop a dark green upper surface with a whiter underside. In autumn, the leaves transition to a yellow shade with distinctive rusty spots. Witch hazel blooms between late autumn and winter, occasionally extending to February. The flowers of the witch hazel are pale to bright-yellow, sometimes red or orange, and consist of four ribbon-like petals. They are accompanied by four short stamens and grow in dense collections. Flowering begins in mid-autumn and persists until late autumn. The calyx is four-parted, densely pubescent, and orange-brown on the inner surface. Two or three bractlets are present at the base of each flower. The fruit is a hard, woody capsule, 1.0–1.4 cm long, that matures one year after pollination. When ripening, the capsule rips vigorously at the apex, ejecting two shiny black seeds to distances of up to 10 m from the parent plant [1,23].

2.2. Phytochemical Composition

Despite the recognized medicinal potential of Hamamelis virginiana L., relatively few comprehensive phytochemical studies have been conducted, and much of the existing literature remains outdated. Research shows that various parts of the plant—leaves, bark, twigs, and stems—are rich in phenolic acids, flavonoids, hydrolyzable and condensed tannins, and volatile constituents. The chemical composition of H. virginiana extracts depends strongly on the extraction solvent and method, with water, aqueous ethanol, methanol, acetone, and ethyl acetate yielding various compound profiles. Among the most frequently reported compounds are gallic acid and its derivatives, catechin, epicatechin, hamamelitannin, quercetin and kaempferol glycosides, caffeoylquinic acids, and oligomeric and polymeric proanthocyanidins. Advanced analytical techniques—such as high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry (HPLC-ESI-MS/MS), ultra-high-performance liquid chromatography coupled with mass spectrometry using quadrupole time-of-flight (UHPLC-MS-qToF), and gas chromatography coupled with mass spectrometry (GC-MS)—have enabled precise identification and quantification of these metabolites. Additionally, fractionation methods have facilitated the isolation of complex hydrolyzable tannins. The marked variation in chemical profiles based on extraction parameters highlights the need for standardized methodologies in phytochemical research.
Leaf extracts, particularly those obtained using hot water or acetone–water mixtures, demonstrated the greatest diversity of phenolic compounds. Duckstein and Stintzing used HPLC-ESI-MS/MS analysis to identify several derivatives of caffeic and quinic acids—namely, 3-, 4-, and 5-caffeoylquinic acids—as well as flavonoid glycosides, including quercetin rutinoside, kaempferol hexoside, and kaempferol–galloyl hexoside [24]. Amêndola et al. demonstrated that methanolic leaf extracts also contained a wide array of bioactive compounds, including chlorogenic, ferulic, caffeic, ellagic, and salicylic acids, along with flavonoids such as apigenin, luteolin, and myricetin, and their respective glycosides (e.g., luteolin-7-o-glucoside, quercitrin, and rutin) [25]. Piazza et al., while studying glycolic extracts from twigs and bark, identified a broad spectrum of flavan-3-ols, including catechin, epicatechin, gallocatechin, and epigallocatechin, as well as the hydrolyzable tannin hamamelitannin. Using ultra-performance liquid chromatography coupled with triple quadrupole tandem mass spectrometry (UPLC/QqQ-MS/MS), they also detected additional phenolic acids such as ferulic, gallic, and protocatechuic acids, along with flavonoids like quercetin, isorhamnetin, and naringenin [26]. Wang et al. investigated water–ethanol extracts using HPLC-UV analysis, which confirmed the presence of gallic acid and hamamelitannin in both bark and leaves [27].
In turn, the fractionation of aqueous ethanol extracts has confirmed the presence of pentagalloyl glucose and tannic acid. UHPLC-MS qToF analysis further revealed a comprehensive profile of gallotannins in leaf extracts, spanning mono- to decagalloyl hexoses, including 1-o-galloyl-β-d-glucose and hamamelitannin [28]. Furthermore, Djapić demonstrated the presence of additional compounds in methanolic leaf extracts, including chlorophyll catabolites such as bilin-type and bilinone-type degradation products, as determined by HPLC analysis [29].
In addition to polyphenols, volatile compounds represent another class of phytochemicals that have been studied in H. virginiana. Engel et al. performed a steam distillation and water extraction of leaves and bark, which enabled the identification of over 170 volatile constituents. These included aliphatic hydrocarbons, alcohols, aldehydes, ketones, and esters. The chemical composition of the volatile fraction varied depending on the raw material used. In the leaf extracts, the major components are hydrocarbons (62.85%), monoterpenes (7.36%), terpenes (3.94%), and aldehydes (3.79%), followed by esters (0.95%), alcohols (0.86%), and ketones (0.83%). In comparison, bark extracts contain hydrocarbons (45.42%), terpenes (21.17%), monoterpenes (8.34%), alcohols (5.31%), aldehydes (6.14%), ketones (1.55%), esters (0.59%), and phenylpropanoids in significant quantities (over 7%) [30]. Cheesman et al., using GC-MS analysis, also detected a variety of alcohols and ethers containing aromatic rings and exhibiting potential biological activity [31].
Figure 2 illustrates some representatives of specific classes of polyphenolic compounds identified in H. virginiana extracts. Table 1 summarizes the current findings on the phytochemical constituents of H. virginiana, with emphasis on solvent, extraction method, compound identification, and analytical techniques.

3. Biological Activity of H. virginiana

3.1. Traditional Uses and Regulatory Status of H. virginiana in Europe

The leaves and bark of H. virginiana have a long-standing history of use in traditional medicine and herbal remedies, particularly among Native American tribes. They utilized witch hazel preparations for a variety of skin-related ailments, including inflammation, wounds, insect bites, and irritation caused by poison ivy (T. radicans). In folk medicine, witch hazel extracts have been valued for their astringent, anti-inflammatory, and soothing properties. They have been traditionally employed to manage skin disorders such as eczema, psoriasis, and general skin dryness, as well as to alleviate minor injuries, razor burn, and local irritation. Furthermore, a decoction of the bark, due to its astringent properties, has traditionally been used to treat hemoptysis, hematemesis, and other types of hemorrhages, as well as diarrhea, dysentery, excessive mucous discharges, and hemorrhoids [2,5,40].
Beyond North America, the therapeutic use of H. virginiana has also become widespread in Europe. In countries such as Poland and Ukraine, witch hazel-based preparations have been used in ethnobotanical practices to treat inflammatory skin conditions and promote skin regeneration. Similarly, in the South Balkan and Eastern Mediterranean Region, traditional medicine has incorporated witch hazel for centuries, particularly in topical applications aimed at reducing swelling, redness, and irritation associated with minor dermatological complaints. Distilled witch hazel has traditionally been used to temporarily soothe eye irritation caused by dryness or environmental factors such as wind and sunlight [6,7,8].
The European Medicines Agency (EMA) has published two monographs on witch hazel—one for the bark and the other for the leaves. Both publications contain documented information on the medicinal use of the extracts. The monographs provide details on possible herbal preparations derived from raw materials, including the following: dried, comminuted herbal substance; tincture (fresh leaves) (ratio of herbal substance to extraction solvent 1:10, extraction solvent: ethanol 45% v/v); liquid extract (fresh leaves) (DER 1:1, extraction solvent: ethanol 45% v/v); liquid extract (DER 1:1, extraction solvent: ethanol 30% m/m); liquid extract (DER 1:2, extraction solvent: ethanol 60% v/v); and dry extract (DER 5–7.7:1, extraction solvent: ethanol 30% m/m). The documents also specify the forms and routes of safe administration (cutaneous, oromucosal, rectal, and anorectal) and indicate that the therapy is safe, with little or no side effects other than skin irritation, and no risk of overdose [41,42]. The reports also establish traditional therapeutic indications based on well-established usage for both pharmaceutical materials (cortex and folium): for the relief of minor skin inflammation and dryness, the symptomatic relief of itching and burning associated with hemorrhoids, and as a mouth and throat rinse to relieve minor inflammation of the oral mucosa. The authors specify that these products are traditional herbal medicinal products intended for use in the specified indications exclusively based on long-standing use [41,42].
The European Scientific Cooperative on Phytotherapy (ESCOP) has also issued its own specifications for these two pharmaceutical raw materials. The authors of the reports focused on similar aspects, such as preparation from plant material, forms of administration, applications, and safety, also adding information on the content of active compounds. They brought together relevant data on the possible physiological roles of Hamamelis leaf and bark extracts and their major constituents [43,44].

3.2. Literature-Based Insights into the Skin-Related Bioactivity of H. virginiana

In the context of potential benefits for skin health, several biological activities of H. virginiana extracts are particularly important to investigate, including antimicrobial, antioxidant, anti-inflammatory activities, wound healing effects, and UV protection. The antioxidant action helps neutralize free radicals, which are a major contributor to skin aging and cellular damage. Anti-inflammatory properties are also crucial, as they help prevent chronic inflammation that accelerates skin aging. Moreover, antimicrobial activity is especially relevant for products aimed at acne-prone or sensitive skin, where controlling microbial balance is essential. The extract’s potential to promote skin cell regeneration and support wound healing is equally important, as these processes are vital for maintaining healthy, resilient, and youthful-looking skin. Finally, UV-protective properties can help shield the skin from photoaging and other harmful effects of sun exposure.
Figure 3 presents the main directions of action studied in the case of H. virginiana extracts.

3.2.1. Antibacterial Effects

Due to its unique chemical composition, H. virginiana appears to be a promising antibacterial agent, and its antibacterial and antifungal properties have been extensively studied, covering both Gram-negative and Gram-positive bacteria. It should be noted that these two types of bacteria differ significantly in their cell wall structures, and therefore, distinct molecular mechanisms are involved in the bactericidal and bacteriostatic effects against Gram (−) and Gram (+) strains.
The most common parameter used to assess antibacterial activity is the minimum inhibitory concentration (MIC), which is the lowest concentration that shows no visible bacterial growth in broth. In agar-based assays, activity is often measured by the zone of inhibition (ZOI), defined as the radius of the clear area surrounding a disk infused with the antimicrobial agent. Additionally, the minimum bactericidal or fungicidal concentration (MBC/MFC), representing the lowest concentration that reduces microbial viability by 99.9%, is sometimes evaluated.
Numerous studies have confirmed the effectiveness of both the leaves and bark of H. virginiana against various pathogens, including antibiotic-resistant strains. Cheesman et al. tested leaf extracts obtained using solvents of varying polarity against a sensitive bacterial strain and clinical isolates expressing extended-spectrum beta-lactamases (ESBLs), including Escherichia coli, ESBL E. coli, Klebsiella pneumoniae, ESBL K. pneumoniae, Staphylococcus aureus, and methicillin-resistant S. aureus (MRSA). The ethyl acetate, hexane, and chloroform extracts showed no activity. However, the water and methanolic extracts demonstrated antibacterial effects, with zones of inhibition (ZOI) ranging from 8 to 12 mm. The extracts were more effective against ESBL E. coli compared to sensitive E. coli and showed greater potency against MRSA than against S. aureus. Additionally, they evaluated the effects of combining these extracts with common antibiotics, finding additive interactions in three combinations: aqueous or methanolic extracts with tetracycline against MRSA, and methanol extract combined with chloramphenicol against E. coli. It is worth noting that additive interactions enhance efficacy, which may allow for lower antibiotic doses and thereby help minimize the risk of side effects [31]. The same experimental protocol was used to test the activity of the extracts against several Staphylococcus spp. (S. oralis, S. pyogenes, S. mutans) and Streptococcus spp. (S. epidermidis, S. aureus) strains. Similarly to previous findings, only the water and methanolic extracts showed activity. These extracts inhibited the growth of S. oralis, S. pyogenes, S. epidermidis, and S. aureus in both semi-solid and liquid cultures. However, S. mutans exhibited near-complete resistance to H. virginiana. Additive interactions were observed with the aqueous extract combined with chloramphenicol against S. oralis and with the methanol extract combined with ciprofloxacin against S. aureus [45]. The water and methanol extracts were also active against P. aeruginosa. Interestingly, combining these extracts with ciprofloxacin reduced the antimicrobial potency of each component when compared to their individual effects; therefore, these agents should not be used in combination [46].
The antimicrobial activity of the decoctions and methanol extracts from the leaves was also observed against anaerobic and facultative aerobic periodontopathic bacteria, including Porphyromonas gingivalis, Porphyromonas asaccharolytica, Prevotella melaninogenica, Prevotella intermedia, Fusobacterium nucleatum, Capnocytophaga gingivalis, Veillonella parvula, Eikenella corrodens, Peptostreptococcus micros, and Actinomyces odontolyticus. Similarly to the findings of Cheesman et al., Iauk et al. observed that methanol extracts demonstrated stronger antibacterial activity than decoctions, which are typically prepared by boiling in water [47]. The study also shows that rinsing with Hamamelis tea reduces initial bacterial colonization and increase the salivary pellicle thickness, thereby supporting oral hygiene and helping to prevent diseases such as caries and periodontitis [48]. In turn, Amêndola et al. investigated the antifungal effects of propylene glycol leaf extract, finding that it acts as a fungicide against Candida spp. (including C. albicans, C. dubliniensis, C. glabrata, C. guilliermondii, C. krusei, and C. tropicalis) [25,49]. However, its antibacterial activity against Acinetobacter baumannii, E. coli, Enterococcus faecalis, K. pneumoniae, S. aureus, and S. mutans was significantly lower, with even MIC values reaching over 50 mg/mL [25]. The study also examined the reduction in microbial biofilms after 5 min and 24 h of treatment using H. virginiana extracts. The extract was effective, but the results were strongly dependent on concentration and time. After 5 min, a concentration of 100 mg/mL led to an over 75% reduction in biofilm for most Candida spp., with the exception of C. krusei, which showed a 56% reduction. Less effectiveness was observed with bacterial strains, where biofilm reduction ranged from 52% to 79% at 100 mg/mL, except for E. coli, where 50 mg/mL resulted in a 75% reduction in biofilm. After 24 h, a concentration of 12.5 mg/mL reduced the biofilm formation of Candida spp., E. coli, and K. pneumoniae by over 79%. The least effective result was observed with E. faecalis, where 50 mg/mL produced a biofilm reduction of 91%. Both S. aureus and S. mutans showed a reduction of 93% at a concentration of 25 mg/mL [25]. The effectiveness of an alcoholic extract from H. virginiana in inhibiting the biofilm of clinical isolates of S. aureus was also demonstrated by Pereira et al. [50].
Rasooly et al. conducted research on the antibacterial properties of the commercial product whISOBAX (witch hazel bark ethanolic-water extract). They found that it suppresses bacterial growth and inhibits pathogenic mechanisms, including biofilm formation and toxin production. The greatest activity was observed against S. epidermidis, S. aureus, Enterococcus faecium, and E. faecalis, followed by Acinetobacter baumannii and Klebsiella pneumoniae. In contrast, the effects on Escherichia coli, Pseudomonas aeruginosa, Streptococcus agalactiae, and Streptococcus pneumoniae were significantly weaker. Furthermore, the extract acted synergistically with linezolid and chloramphenicol and showed cumulative effects with vancomycin and amikacin against S. aureus [51]. Additionally, its combination with green tea enhanced antibacterial activity against S. epidermidis and S. aureus [52]. Interestingly, despite its inhibitory effect on the growth and biofilm formation of pathogenic bacteria, whISOBAX has been found to stimulate the probiotic bacterium Lactobacillus plantarum in a nutritionally limited environment, while also sustaining its growth in a nutrient-rich environment [53]. It also protected against cell death induced by aerobic growing conditions [54]. Therefore, the authors concluded that it may support the maintenance of a healthy microbiome in the organism.
The literature data on the antibacterial and antifungal effects of H. virginiana extracts are summarized in Table 2.
The antibacterial activity of witch hazel has been utilized in complex formulations. It was found that witch hazel bark extract (whISOBAX) enhances the antibacterial effects of commercially available teat dips, which can help prevent bacterial infections in dairy cattle [58]. Furthermore, a formulation with Hamamelis distillate and urea showed an inhibitory effect on S. aureus and Candida albicans [12]. In turn, hazel leaf extract in combination with Krameria lappacea root and Salix alba bark was used to develop a novel formulation with potential application in managing symptoms associated with seborrheic dermatitis. Both alone and when in the mixture, hazel extract was effective against MSSA, MRSA, Bacillus cereus, Enterococcus faecalis, and Salmonella enterica, and it showed no cytotoxicity on human keratinocytes [39]. Interestingly, Nardini et al. showed that extracts of H. virginiana may be useful in antimicrobial photodynamic therapy, as it exhibits photosensitizing properties combined with low toxicity to fibroblast cells and could therefore serve as an alternative to conventional photosensitizers [59].
In addition, attempts have also been made to develop antibacterial materials containing H. virginiana extract with potential applications such as wound dressings. However, these efforts have yet to yield successful results. For example, Solis-Arevalo et al. investigated the antibacterial and antifungal properties of leaf extract on its own and observed a significant inhibition of Staphylococcus aureus, Candida albicans, and Pseudomonas aeruginosa. Nevertheless, when they incorporated the extract into schizophyllan-based membranes, they did not observe any antibacterial effect [60]. Similarly, a lack of antibacterial activity was observed by Molin et al., who developed a bacterial cellulose membrane with aqueous and glycolic extracts of witch hazel and tested it against S. aureus, E. coli, and C. albicans [61]. The authors suggested that the concentration of active compounds in the materials prepared in this way is too low. On the other hand, newly developed bio-packaging material based on linseed mucilage with incorporated H. virginiana leaf extract effectively decreased foodborne pathogens, including L. monocytogenes, S. Typhi, S. aureus, and E. coli, with zones of inhibition ranging from 19.50 to 22.50 mm [55].
The antiviral efficacy of H. virginiana was also documented. Theisen et al. demonstrated the antiviral effects of bark and leaf extracts (60% ethanol), fractions containing tannins of different molecular weights, and individual tannins against influenza A virus (IAV) and human papillomavirus (HPV). They found that the antiviral effect of the leaf extract was similar to that of the bark extract, but the latter demonstrated lower cytotoxicity. High molecular weight condensed tannins, obtained via ultrafiltration, exhibited the highest activity. This fraction, along with the bark extract, inhibited the early stages and, to a lesser extent, later stages of the IAV life cycle and also prevented HPV attachment. Interestingly, high molecular weight tannins inhibited both IAV receptor binding and neuraminidase activity. In contrast, low molecular weight compounds, such as gallic acid, epigallocatechin gallate, and hamamelitannin, inhibited neuraminidase but not hemagglutination [32]. Hemagglutinin and neuraminidase are glycoproteins that play essential roles in the infection cycle, facilitating the initial attachment of the virus to the host cell and aiding in the release of newly formed viral particles from the host cell, respectively. Notably, the activity of the fractions and the extract was superior to that of the individual isolated compounds [32]. The fraction containing oligomeric and polymeric proanthocyanidins isolated from the hydroethanol extract of H. virginiana bark exhibited significant antiviral activity against herpes simplex virus type 1 (HSV-1) [62]. On the other hand, a standardized dry extract of H. virginiana leaf, obtained using 50% ethanol, showed no anti-HIV activity in infected human lymphocytic cells [63].

3.2.2. Anti-Inflammatory Activity

Anti-inflammatory activity is another important feature of plant extracts in the context of skin health. In addition to directly soothing inflammatory conditions, anti-inflammatory agents can help counteract chronic low-grade inflammation, known as ‘inflammaging,’ by reducing the production of pro-inflammatory cytokines and oxidative stress. The effects of H. virginiana on various inflammatory mediators have been extensively studied, primarily using cell models with induced inflammation.
Piazza et al. investigated the potential of a standardized bark extract against eczema (AD) using human keratinocytes (HaCaT cells) induced with various cytokines including TNF-α (tumor necrosis factor alpha), IL-4 (interleukin 4), and a mixture of TNF-α/IL-4 and TNF-α/IFN-γ (interferon gamma) [64]. They found that the extract suppressed the release of mediators related to skin autoimmunity—IL-6 and IL-17C—and allergy—TSLP (thymic stromal lymphopoietin), IL-6, CCL26 (chemokine (C-C motif) Ligand 26), and MMP-9 (matrix metalloproteinase). All of these biomarkers are important contributors to the pathogenesis of the inflammatory processes in AD. However, the activity of the extract was only partially attributed to the hamamelitannin content, as this compound affected only TSLP and CCL26 and showed no inhibitory effect on the other factors investigated. The mechanism of action of the extract involved the disruption of NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells)-driven transcription. Additionally, it inhibited the proliferative effects of IL-4 and restored the expression of K10, a protein marker of skin differentiation [64]. In another study, Piazza et al. found that the extract decreased IL-6 and IL-8 levels in HaCaT cells infected with Cutibacterium acnes and IL-8 levels in HaCaT cells stimulated with TNF-α. Although it showed no inhibitory effect on bacterial growth, the observed anti-inflammatory properties could be beneficial in acne treatment. The results suggest that the biological activity of the extract is associated with its abundance of epicatechin-3-gallate [26].
In turn, Amêndola et al. evaluated the effect of the H. virginiana extract leaf on murine macrophages (RAW 264.7 cell line) stimulated with lipopolysaccharide (LPS) and found that the propylene glycol extract suppressed the production of IL-1β and TNF-α. The extract also reduced nitric oxide (NO) levels [25]. It is worth mentioning that although NO supports controlling infections by helping to eliminate pathogens through its antimicrobial and cytotoxic effects, excessive or prolonged NO production can contribute to tissue damage and promote chronic inflammation.
The anti-inflammatory activity of H. virginiana can also be associated with the inhibition of lipoxygenase (LOX), an enzyme that plays a key role in the metabolism of arachidonic acid and contributes to the production of leukotrienes and prostaglandins. This was documented in a study by Hartisch et al., who observed that galloylated proanthocyanidins isolated from the extract suppressed 5-LOX activity [65]. In turn, Manville et al. stated that the dual anti-inflammatory and analgesic effects of witch hazel bark extract may result from the polymodal modulation of multiple potassium channel types [66]. An in vivo study by Erdelmeier et al. also confirmed the anti-inflammatory activity of H. virginiana. They observed that proanthocyanidins from the hydroethanol extract from bark exhibited strong anti-inflammatory effects in croton oil-induced dermal inflammation in mice [62]. In the study by Liu et al. [67], it was demonstrated that witch hazel inhibited the TNFα-induced expression of cytokines IL-1α, IL-1β, IL-8, and PGE2 (prostaglandin E₂) in HaCaT cells. The anti-inflammatory effect was further confirmed ex vivo in skin tissue with induced inflammation using a commercially available Cell Stimulation Cocktail, as the extract significantly decreased the levels of IL-6, IL-17A, TNFα, and IFN-γ compared to the control. Additionally, an analysis of skin barrier function markers, such as loricrin and transglutaminase-1, showed notable increases compared to the inflamed control, indicating improvements in skin integrity [67]. However, it should be noted that no data is given regarding the type of extract and even the part of plants taken for investigation.
The data regarding the anti-inflammatory activity of H. virginiana, including experimental models and observed effects, are compiled in Table 3.

3.2.3. Wound Healing Properties and the Other Effects on Skin

Wound healing is a complex, multi-stage process involving hemostasis, inflammation, cell proliferation, and tissue remodeling. After bleeding is stopped, an inflammatory response is triggered to prevent infection. In the next stage, there is increased cell proliferation, where new tissue and blood vessels form. Finally, in the remodeling phase, the tissue strengthens and matures [69].
Antibacterial activity is a critical feature in wound healing, as it helps create a microorganism-free environment and prevents wound infections. Similarly, anti-inflammatory action is essential to suppress prolonged inflammation, which is undesirable because it can lead to excessive tissue breakdown and inhibit effective tissue repair [70]. In this context, H. virginiana, which exhibits both types of activities, appears promising.
Another aspect to consider in wound healing is the regulation of proteolytic and oxidative enzymes at the wound site. Proteolytic enzymes, such as matrix metalloproteinases (MMPs), help clear damaged tissue and enable cell migration, while oxidative enzymes contribute to pathogen defense by producing reactive oxygen species (ROS). On the other hand, excessive enzyme activity can degrade the extracellular matrix (ECM) and, therefore, harm healthy tissue. Thus, maintaining an appropriate balance of these enzymes is crucial for optimal healing [69,71].
Several studies describe the effects of H. virginiana extracts on various aspects related to wound healing. Dezena and da Silva, who investigated the impact of a tincture prepared by percolation with 70% ethanol (10% w/v) on dewaxed and hydrated skin fragments from Wistar rats, found that it exhibited significant proteolytic activity on collagen and elastic fibers but did not affect epithelial and connective tissue cells, epidermal attachments, pigments, or granules [72]. Thring et al. observed that the water extract from the aerial parts and the distillate inhibited elastase, and additionally, the water extract showed anti-collagenase activity [68,73]. This type of activity could also be significant in anti-aging activity. Furthermore, polyphenols from H. virginiana stems, used in the preparation of collagen sponges for chronic wound dressings, demonstrated a suppression of two major enzymes that impair the wound healing process—myeloperoxidase (MPO) and collagenase [74]. Rocasalbas et al. used the phenolic fraction, consisting of a mixture of proanthocyanidin dimers and hydrolysable tannins (hamamelitannin, pentagalloyl glucose, and methyl gallate) isolated from stems, to develop bioactive hydrogel dressings. The hydrogels inhibited the growth of S. aureus and P. aeruginosa, bacteria which are commonly found in chronic wounds, and demonstrated inhibitory capacity against myeloperoxidase and collagenase [75]. It was also observed that the proanthocyanidins isolated from bark significantly increased the proliferation of human skin keratinocytes [34].
The protective effects of H. virginiana extract on skin have also been reported. Ramos et al. indicate that H. virginiana extract has potential as an antisolar agent, as evidenced by spectrophotometric measurements of sun protection factors and UV absorption [76]. In turn, Choi et al. found that H. virginiana can be a valuable ingredient in anti-pollution skincare products, as the extract from its stem and leaves lowered Ca²⁺ influx in HaCaT cells stimulated by particulate matter (PM2.5). The mechanism of action involved proteinase-activated receptor-2 (PAR-2), NF-κB, and occludin. The extract supported HaCaT cells in recovering from DPM-induced damage. The increased levels of PAR-2 (A) and NF-κB (B) induced by DPM were reduced to, or below, normal levels. Additionally, the decreased level of occludin caused by DPM returned to a normal state. This effect was attributed to hexagalloylglucose, isolated from the extract, which alone exhibited this type of activity [77].
In another study, the fractions from witch hazel bark rich in galloylated tannin showed anticancer potential against melanoma, with only mild cytotoxic effects on human skin fibroblasts and keratinocytes. Additionally, it was found to act as an antihemolytic agent, protecting red blood cells from hemolysis induced by oxidative stress [33].

3.2.4. Antioxidant Activity

Antioxidant activity is the most commonly studied type of action in the case of plant extracts because its ability to scavenge free radicals can support the skin’s defense mechanisms against oxidative stress. This is particularly important in protecting the skin from premature aging, inflammation, and damage caused by environmental factors such as UV radiation and pollution. The antioxidant properties of H. virginiana were documented in many studies based on common chemical tests including DPPH, ABTS, and ORAC [25,26,57,78]. H. virginiana has also been found to actively scavenge singlet oxygen, superoxide anion radicals, hydroxyl radicals, and peroxynitrite, and it has been shown to prevent the oxidation of lipid bilayers [79,80,81]. Cells-based assay confirmed the antioxidant effects of both extracts and isolated components. It has been found that H. virginiana protects murine dermal fibroblasts against oxidative stress [79] and decreased reactive oxygen species (ROS) levels in H2O2-stimulated HaCaT [26]. However, this effect was not associated with an influence on catalase, one of the main enzymes responsible for maintaining redox balance in the cell, as no impact on the enzyme’s activity was observed [26,68]. The direct antioxidant effects of the water extract from the aerial parts was also demonstrated in Caco-2 and HepG2 cells, as shown by the Antioxidant Power 1 (AOP1) assay, which measures the ability to neutralize intracellular free radicals produced by photo-induction. This effect was associated with the modulation of the ARE/Nrf2 (antioxidant response element/nuclear factor erythroid 2–related factor 2) transcriptional pathway, which regulates the expression of numerous proteins involved in cellular antioxidant systems [82]. In turn, Liu et al. investigated the efficacy of witch hazel in mitigating UVA-induced oxidative stress and found a significant reduction in ROS levels when skin samples were pretreated with witch hazel formulations. Furthermore, treatment with the WH formula resulted in a significant decrease in 4-hydroxynonenal, a byproduct of the oxidation of sebum and keratinocyte cell membrane lipids, which had been significantly increased by UVA exposure [67].

3.2.5. In Vivo Studies

Although in vivo studies on Hamamelis are limited, several investigations have examined its skin-related effects. Hughes-Formella et al. found that a topical lotion containing a 10% distillate of H. virginiana effectively reduced erythema induced by UV irradiation [83,84]. Furthermore, its extract has been effective in treating accidental skin injury caused by sodium hypochlorite solution during dental treatment. The extract alleviated burning and tenderness, and, after three months, reduced skin discoloration [85]. In turn, Wolff and Kieser assessed the clinical effects of a Hamamelis ointment containing a distillate of leaves and bark for treating inflammation and minor skin injuries in young patients up to the age of 11. They reported that ratings of the treatment by physicians and parents were similar to or even better than those for dexpanthenol [86]. A randomized controlled prospective cohort study conducted by Veronese et al. demonstrated that a cream for the eyelids and eye contour area with H. virginiana bark extract improved symptoms of eyelid dermatitis [87]. The anti-inflammatory effectiveness of oil-in-water emulsions containing H. virginiana distillate was also tested by Korting et al. in humans with inflammation induced by UV irradiation and cellophane tape stripping. They found that the emulsions reduced UV-induced erythema [88]. The emulsion also reduced itching and erythema in patients with atopic eczema; however, its effect was lower than that of hydrocortisone cream [89]. Moreover, a retrospective observational study by Trüeb, which included 1373 of patients, showed the effectiveness of witch hazel-based shampoo and tonic for the treatment of sensitive scalp irritation [17].
A preliminary in vivo evaluation of Hamamelis procyanidins further supports their skin benefits. A semi-solid formulation containing 1% Hamamelis procyanidins was tested for its ability to prevent irritant contact dermatitis induced by sodium lauryl sulfate (SLS) [34]. SLS irritation caused an increase in transepidermal water loss (TEWL), indicating local barrier disruption, but treatment with Hamamelis procyanidins significantly reduced this TEWL increase. Preventing TEWL is crucial for maintaining healthy skin because loss of moisture leads to dryness and irritation. An impaired skin barrier also makes the skin more susceptible to environmental aggressors, allergens, and pathogens, which can trigger inflammation and various skin disorders. Furthermore, pretreatment with the Hamamelis formulation clearly reduced clinical signs of inflammation. These findings were corroborated by colorimetry measurements assessing skin redness: SLS-induced irritation significantly increased erythema, which was noticeably reduced following treatment with procyanidins [34].
There are also a few studies concerning the effects of H. virginiana when taken orally. Natella et al. investigated the activity of aerial parts H. virginiana extract (Hamaforton™ capsule with 300 mg of the extract) on gene dysregulation induced by UVA radiation in human dermal fibroblasts, using a combination of in vivo and ex vivo experiments. In the first part of the study, 12 healthy volunteers received either Hamaforton™ or a placebo in a randomized, blinded crossover trial. In the next phase, serum containing Hamaforton™ metabolites—including 4-O-methyl gallic acid, 4-O-methyl gallic acid sulfate, and trimethyl gallic acid glucuronide—was used to enrich the culture medium of dermal fibroblasts exposed to UVA. Natella et al. observed an increase in the expression of ten genes associated in repair processes critical for the maintenance of skin integrity, suggesting that these metabolites may play a role in damage recovery [90]. In turn, Duwiejua et al. investigated the anti-inflammatory effects of a 70% ethanol leaf extract administered before and after the induction of rat paw edema. They found that H. virginiana was effective when administered after inflammation was induced, but it was only effective in the chronic state [91].

3.3. Biological Activity of Hamamelitannin

The most characteristic compound found in H. virginiana is hamamelitannin, which is present in the bark, stem, and leaves. This compound, together with other galloylated proanthocyanidins, contributes to the biological activity of the plants. Hamamelitannin isolated from H. virginiana exhibits potent free radical scavenging activity, as demonstrated in various chemical assays, including DPPH [92,93]. It has been identified as a strong inhibitor of 5-lipoxygenase (5-LOX), an enzyme involved in the progression of inflammation [65]. Masaki et al. found that hamamelitannin exerts protective effects against superoxide-induced damage in murine fibroblasts, showing greater activity than gallic acid, which constitutes its functional units [94]. Additionally, it demonstrated protective activity against UVB-induced cell damage in murine skin fibroblasts [95]. It has also been found to prevent the depolymerization of hyaluronic acid caused by oxidative stress [96].
The antimicrobial effects of hamamelitannin have also been reported. It has been found that hamamelitannin was effective against S. aureus isolates resistant to various antimicrobials and was able to inhibit biofilm production [97]. In a study by Cobrado et al. conducted in mice, it was demonstrated that subcutaneously implanted catheters previously soaked in a hamamelitannin solution exhibited significant infection control against S. aureus, S. epidermidis, and Acinetobacter baumannii. This compound reduced both the metabolic activity and biomass of the biofilm [98]. Hamamelitannin also showed antiviral efficacy against influenza A virus and human papillomavirus, with its mechanism of action involving neuraminidase inhibition [32]. The anti-inflammatory activity of hamamelitannin was studied by Piazza et al. in HaCaT cells stimulated with various inflammatory agents, including TNF-α, IL-4, TNF-α/IL-4, and TNF-α/IFN-γ. They observed a decrease in the expression of TSLP and CCL26, with no significant effect on IL-17C, MMP-9, or IL-6 [26,64].

4. A Global Regulation and Market Status of H. virginiana

H. virginiana has a long-standing tradition of use in both medicinal and cosmetic formulations across the globe. Its pharmacological properties, such as its anti-inflammatory, antioxidant, and wound-healing effects, have contributed to its popularity. However, the regulatory status and market presence of witch hazel in products vary significantly between regions such as the United States, the European Union, and parts of Asia.
In the USA, Hamamelis virginiana distillate (commonly referred as witch hazel water) is an over-the-counter (OTC) product regulated by the U.S. Food and Drug Administration (FDA). It is officially listed in the United States Pharmacopeia (USP) and is widely used in topical applications for minor skin irritations, insect bites, and hemorrhoidal relief. Cosmetic formulations containing witch hazel—toners, cleansers, and aftershaves—are classified as cosmetics under FDA regulation, provided that they do not exhibit any therapeutic effects, but act as an astringent ingredient [99,100].
In the European Union, witch hazel preparations can be used as a traditional herbal medicinal product (THMP) under Directive 2004/24/EC or as cosmetic products under Regulation (EC) No 1223/2009. Examples of THMPs include creams, rectal suppositories or liquid preparations for the treatment of minor inflammatory conditions of the skin. Regulatory assessment is carried out by national agencies or by the European Medicines Agency (EMA). In addition, the leaves and bark extracts of H. virginiana are registered for their cosmetic use in the European Cosmetics Ingredients database (CosIng) as astringents, skin and hair conditioners, and soothing ingredients [41,42,101].
In Asia, legal regulations are more dependent on the region and country. In countries like Japan, witch hazel extract is primarily used in the cosmetics industry, especially in facial care products. These products are regulated as quasi-drugs or functional cosmetics, depending on the national legislation of the Japanese Ministry of Health, Labor and Welfare (MHLW) [102]. For instance, witch hazel water is approved as a skin-conditioning agent. In China, products containing H. virginiana may fall under the regulatory oversight of the National Medical Products Administration (NMPA) [103], with the most recent focus predominantly being on the botanical ingredients of cosmetics, supporting the consumers demand for “clean beauty” solutions in these products. However, the formal recognition of using witch hazel in these regions as a traditional medicine is limited.

5. Conclusions

Our study showed that Hamamelis virginiana (witch hazel) demonstrates a wide range of biological activities that support its use in dermatology, particularly regarding skin health. Extracts from its bark and leaves show antibacterial, antifungal, antiviral, anti-inflammatory, antioxidant, and wound healing properties. It is effective against various bacteria, including antibiotic-resistant strains, and fungi like Candida, with synergistic effects alongside antibiotics. Clinical studies support its use in eczema, acne, UV-induced erythema, and sensitive scalp conditions. Hamamelis also promotes wound healing by modulating enzymes, reducing oxidative damage, and stimulating skin cell growth. Its antioxidant properties protect skin from oxidative stress and pollution. Taken together, current scientific evidence confirms the relevance of H. virginiana as a traditional herbal remedy. Its multifunctional bioactivity, wide availability, and favorable safety profile position it as a promising candidate for integration into modern dermatological and cosmetic formulations. The future potential of witch hazel lies not only in its traditional uses but also in novel applications supported by rigorous scientific validation. Therefore, despite these promising findings, several areas require further investigation.
The molecular mechanisms responsible for the biological effects of H. virginiana are worth investigating, with particular emphasis on the regulation of intracellular signaling pathways. Clarifying which signaling cascades are selectively activated or suppressed by its bioactive compounds could contribute to the identification of specific molecular targets. This knowledge would not only help explain its pharmacological actions—such as its anti-inflammatory, antioxidant, or antimicrobial effects—but could also aid in optimizing therapeutic applications and minimizing potential side effects. Variability in extract composition highlights the necessity for standardized extraction protocols and comprehensive phytochemical profiling. It is also worth including the flowers of this interesting plant in future studies, as they may prove to be a valuable source of beneficial phytochemicals. Additionally, while environmental and geographical factors are known to influence the phytochemical content of many medicinal plants, there are currently no published studies examining whether the efficacy or composition of H. virginiana extracts vary depending on the cultivation region. Addressing this gap could provide valuable insights for optimizing cultivation practices and ensuring consistent therapeutic quality. Furthermore, although preliminary clinical results are encouraging, larger and well-controlled trials are essential to confirm efficacy in specific skin conditions. Moreover, long-term safety and toxicity profiles of different formulations, especially at higher concentrations, remain insufficiently explored. Research into optimal delivery systems, such as emulsions and hydrogels, to improve the bioavailability of active compounds in topical applications is also warranted. Lastly, further studies on synergistic or antagonistic interactions with conventional antibiotics and skincare agents are critical to inform effective combination therapies.
In conclusion, H. virginiana represents a multifaceted natural agent with significant potential for skin health and is deserving of continued translational and clinical research to fully harness its therapeutic benefits.

Author Contributions

Conceptualization, M.W., I.S., F.G., D.Z., and M.F.; methodology, M.W., I.S., F.G., D.Z., and M.F.; software, M.W., F.G., and I.S.; investigation, M.W., W.P., I.S., F.G., D.Z., and M.F.; data curation, M.W., D.Z., and I.S.; writing—original draft preparation, M.W., W.P., I.S., F.G., D.Z., and M.F.; writing—review and editing, M.W., W.P., F.G., D.Z., and I.S.; visualization, M.W., I.S., D.Z., and F.G.; supervision, M.W., I.S., and D.Z.; project administration, M.W., I.S., F.G., D.Z., and M.F. funding acquisition, M.W., M.F., and I.S. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by Medical University of Lublin (DS 51 and DS 52).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Meyer, F.G. Flora of North America North of Mexico (FNA); Oxford University Press: New York, NY, USA; Oxford, UK, 1997. [Google Scholar]
  2. Andriote, J.-M. The Mysterious Past and Present of Witch Hazel. The Atlantic, 6 November 2012. [Google Scholar]
  3. Smith, R.A.; Koch, V. Blink and You’ll Miss These Plants Shooting Their Seeds; Duke University: Durham, NC, USA, 2023. [Google Scholar]
  4. Bingham, M.C. Which Witch Is Witch Hazel (and Which Dickinson Makes It)? Connecticut Business Journal: Hartford, CT, USA, 1997. [Google Scholar]
  5. Gangemi, S.; Minciullo, P.L.; Miroddi, M.; Chinou, I.; Calapai, G.; Schmidt, R.J. Contact Dermatitis as an Adverse Reaction to Some Topically Used European Herbal Medicinal Products—Part 2: Echinacea Purpurea-Lavandula Angustifolia. Contact Dermat. 2015, 72, 193–205. [Google Scholar] [CrossRef] [PubMed]
  6. Melnyk, N.; Vlasova, I.; Skowrońska, W.; Bazylko, A.; Piwowarski, J.P.; Granica, S. Current Knowledge on Interactions of Plant Materials Traditionally Used in Skin Diseases in Poland and Ukraine with Human Skin Microbiota. Int. J. Mol. Sci. 2022, 23, 9644. [Google Scholar] [CrossRef] [PubMed]
  7. Tsioutsiou, E.E.; Amountzias, V.; Vontzalidou, A.; Dina, E.; Stevanović, Z.D.; Cheilari, A.; Aligiannis, N. Medicinal Plants Used Traditionally for Skin Related Problems in the South Balkan and East Mediterranean Region—A Review. Front. Pharmacol. 2022, 13, 936047. [Google Scholar] [CrossRef] [PubMed]
  8. Hanlidou, E.; Karousou, R.; Kleftoyanni, V.; Kokkini, S. The Herbal Market of Thessaloniki (N Greece) and Its Relation to the Ethnobotanical Tradition. J. Ethnopharmacol. 2004, 9, 281–299. [Google Scholar] [CrossRef]
  9. Goglia, M.; Grossi, U.; D’Andrea, V.; Gallo, G. A Pilot Study on the Efficacy and Safety of Preoperative Micronized Purified Flavonoid Fraction Treatment and Sucralfate-Based Rectal Ointment on Patients with Grade II to IV Hemorrhoidal Disease. Acta Phlebol. 2024, 25, 70–75. [Google Scholar] [CrossRef]
  10. Giua, C.; Minerba, L.; Piras, A.; Floris, N.; Romano, F.; SIFAC Group. The Effect of Sucralfate-Containing Ointment on Quality of Life in People with Symptoms Associated with Haemorrhoidal Disease and Its Complications: The Results of the EMOCARE Survey. Acta Bio Medica Atenei Parm. 2021, 92, e2021029. [Google Scholar] [CrossRef]
  11. Mukherjee, P.K.; Maity, N.; Nema, N.K.; Sarkar, B.K. Bioactive Compounds from Natural Resources against Skin Aging. Phytomedicine Int. J. Phytother. Phytopharm. 2011, 19, 64–73. [Google Scholar] [CrossRef]
  12. Gloor, M.; Reichling, J.; Wasik, B.; Holzgang, H.E. Antiseptic Effect of a Topical Dermatological Formulation That Contains Hamamelis Distillate and Urea. Complement. Med. Res. 2002, 9, 153–159. [Google Scholar] [CrossRef]
  13. Draelos, Z.D.; Levy, S.B.; Lutrario, C.; Gunt, H. Evaluation of the Performance of a Nature-Based Sensitive Skin Regimen in Subjects With Clinically Diagnosed Sensitive Skin. J. Drugs Dermatol. JDD 2018, 17, 908–913. [Google Scholar]
  14. Rodrigues Ueoka, A.; Pedriali Moraes, C. Development and Stability Evaluation of Liquid Crystal-Based Formulations Containing Glycolic Plant Extracts and Nano-Actives. Cosmetics 2018, 5, 25. [Google Scholar] [CrossRef]
  15. Barragan-Galvez, J.C.; Gonzalez-Rivera, M.L.; Jiménez-Cruz, J.C.; Hernandez-Flores, A.; De La Rosa, G.; Lopez-Moreno, M.L.; Yañez-Barrientos, E.; Romero-Hernández, M.; Deveze-Alvarez, M.A.; Navarro-Santos, P.; et al. A Patent-Pending Ointment Containing Extracts of Five Different Plants Showed Antinociceptive and Anti-Inflammatory Mechanisms in Preclinical Studies. Pharmaceutics 2024, 16, 1215. [Google Scholar] [CrossRef] [PubMed]
  16. Trüeb, R.M. Efficacy, Tolerability, and Superiority of Propylene Glycol-Free, North American Witch-Hazel (Hamamelis Virginiana)-Based Solution of 5% Minoxidil Sulfate for the Treatment of Female Androgenetic Alopecia. Int. J. Trichol. 2023, 15, 108–112. [Google Scholar] [CrossRef]
  17. Trüeb, R. North American Virginian Witch Hazel (Hamamelis Virginiana): Based Scalp Care and Protection for Sensitive Scalp, Red Scalp, and Scalp Burn-Out. Int. J. Trichol. 2014, 6, 100. [Google Scholar] [CrossRef]
  18. Ueoka, A.R.; Sufi, B.S.; Magalhães, W.V.; Fernandes, L.; Andreo-Filho, N.; Leite-Silva, V.R.; Lopes, P.S. Flow Cytometry as an Alternative Method to Evaluate Genotoxicity of Natural Cosmetic Actives. J. Cosmet. Dermatol. 2023, 22, 958–968. [Google Scholar] [CrossRef]
  19. Turan, Ç.; Öner, Ü. Lip Mesotherapy with Dexpanthenol As A Novel Approach To Prevent Isotretinoin-Associated Cheilitis. Dermatol. Pract. Concept. 2023, 13, e2023012. [Google Scholar] [CrossRef]
  20. Tonetto, M.R.; Bandéca, M.C.; Filho, E.M.M.; Junior, J.C.E.M.; Nunes, L.H.D.A.C.; Arruda, C.S.; De Castro Rizzi, C.; Mouchrek, A.Q.E.S.; Tavarez, R.R.D.J. Effectiveness of Oral Antiseptics on Tooth Biofilm: A Study in Vivo. J. Contemp. Dent. Pract. 2015, 16, 674–678. [Google Scholar] [CrossRef]
  21. Palombo, E.A. Traditional Medicinal Plant Extracts and Natural Products with Activity against Oral Bacteria: Potential Application in the Prevention and Treatment of Oral Diseases. Evid. Based Complement. Altern. Med. 2011, 2011, 680354. [Google Scholar] [CrossRef]
  22. Poondru, S.; Scott, K.; Riley, J.M. Patient Perspectives of Wound Care Management in Hidradenitis Suppurativa. Arch. Dermatol. Res. 2023, 315, 1847–1850. [Google Scholar] [CrossRef]
  23. Anderson, G.J.; Hill, J.D. Many to Flower, Few to Fruit: The Reproductive Biology of Hamamelis Virginiana (Hamamelidaceae). Am. J. Bot. 2002, 89, 67–78. [Google Scholar] [CrossRef]
  24. Duckstein, S.M.; Stintzing, F.C. Investigation on the Phenolic Constituents in Hamamelis Virginiana Leaves by HPLC-DAD and LC-MS/MS. Anal. Bioanal. Chem. 2011, 401, 677–688. [Google Scholar] [CrossRef]
  25. Amêndola, I.; Viegas, D.D.J.; Freitas, E.T.; Oliveira, J.R.D.; Santos, J.G.D.; Oliveira, F.E.D.; Lagareiro Netto, A.A.; Marcucci, M.C.; Oliveira, L.D.D.; Back-Brito, G.N. Hamamelis Virginiana L. Extract Presents Antimicrobial and Antibiofilm Effects, Absence of Cytotoxicity, Anti-Inflammatory Action, and Potential to Fight Infections through the Nitric Oxide Production by Macrophages. An. Acad. Bras. Ciênc. 2024, 96, e20200031. [Google Scholar] [CrossRef] [PubMed]
  26. Piazza, S.; Martinelli, G.; Vrhovsek, U.; Masuero, D.; Fumagalli, M.; Magnavacca, A.; Pozzoli, C.; Canilli, L.; Terno, M.; Angarano, M.; et al. Anti-Inflammatory and Anti-Acne Effects of Hamamelis Virginiana Bark in Human Keratinocytes. Antioxidants 2022, 11, 1119. [Google Scholar] [CrossRef] [PubMed]
  27. Wang, H.; Provan, G.J.; Helliwell, K. Determination of Hamamelitannin, Catechins and Gallic Acid in Witch Hazel Bark, Twig and Leaf by HPLC. J. Pharm. Biomed. Anal. 2003, 33, 539–544. [Google Scholar] [CrossRef] [PubMed]
  28. Burico, M.; Fodaroni, G.; Flamini, E.; Ascani, N.; Proietti, G.; Tamimi, S.; Quintiero, C.M.; Massa, L.; Gianni, M.; Mattoli, L. Metabolomic Fingerprint of Hamamelis Virginiana L. Gallotannins by Suspect Screening Analysis with UHPLC-qToF and Their Semiquantitative Evaluation. J. Mass Spectrom. 2022, 57, e4878. [Google Scholar] [CrossRef]
  29. Djapić, N. Bilin and Bilinone Chlorophyll Catabolite Content in the Hamamelidaceae Autumnal Leaves. Nat. Prod. Sci. 2022, 28, 18–26. [Google Scholar] [CrossRef]
  30. Engel, R.; Gutmann, M.; Hartisch, C.; Kolodziej, H.; Nahrstedt, A. Study on the Composition of the Volatile Fraction of Hamamelis Virginiana. Planta Med. 1998, 64, 251–258. [Google Scholar] [CrossRef]
  31. Cheesman, M.J.; Alcorn, S.R.; White, A.; Cock, I.E. Hamamelis Virginiana L. Leaf Extracts Inhibit the Growth of Antibiotic-Resistant Gram-Positive and Gram-Negative Bacteria. Antibiotics 2023, 12, 1195. [Google Scholar] [CrossRef]
  32. Theisen, L.L.; Erdelmeier, C.A.J.; Spoden, G.A.; Boukhallouk, F.; Sausy, A.; Florin, L.; Muller, C.P. Tannins from Hamamelis Virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papillomavirus. PLoS ONE 2014, 9, e88062. [Google Scholar] [CrossRef]
  33. Touriño, S.; Lizárraga, D.; Carreras, A.; Lorenzo, S.; Ugartondo, V.; Mitjans, M.; Vinardell, M.P.; Juliá, L.; Cascante, M.; Torres, J.L. Highly Galloylated Tannin Fractions from Witch Hazel (Hamamelis Virginiana) Bark: Electron Transfer Capacity, In Vitro Antioxidant Activity, and Effects on Skin-Related Cells. Chem. Res. Toxicol. 2008, 21, 696–704. [Google Scholar] [CrossRef]
  34. Deters, A.; Dauer, A.; Schnetz, E.; Fartasch, M.; Hensel, A. High Molecular Compounds (Polysaccharides and Proanthocyanidins) from Hamamelis Virginiana Bark: Influence on Human Skin Keratinocyte Proliferation and Differentiation and Influence on Irritated Skin. Phytochemistry 2001, 58, 949–958. [Google Scholar] [CrossRef]
  35. Dauer, A.; Hensel, A.; Lhoste, E.; Knasmüller, S.; Mersch-Sundermann, V. Genotoxic and Antigenotoxic Effects of Catechin and Tannins from the Bark of Hamamelis Virginiana L. in Metabolically Competent, Human Hepatoma Cells (Hep G2) Using Single Cell Gel Electrophoresis. Phytochemistry 2003, 63, 199–207. [Google Scholar] [CrossRef] [PubMed]
  36. Dauer, A.; Rimpler, H.; Hensel, A. Polymeric Proanthocyanidins from the Bark of Hamamelis Virginiana. Planta Med. 2003, 69, 89–91. [Google Scholar] [CrossRef]
  37. Sagareishvili, T.G.; Yarosh, E.A.; Kemertelidze, E.P. Phenolic Compounds from Leaves of Hamamelis Virginiana. Chem. Nat. Compd. 1999, 35, 585. [Google Scholar] [CrossRef]
  38. Schulz, H.; Albroscheit, G. High-Performance Liquid Chromatographic Characterization of Some Medical Plant Extracts Used in Cosmetic Formulas. J. Chromatogr. A 1988, 442, 353–361. [Google Scholar] [CrossRef]
  39. Safta, D.A.; Ielciu, I.; Șuștic, R.; Hanganu, D.; Niculae, M.; Cenariu, M.; Pall, E.; Moldovan, M.L.; Achim, M.; Bogdan, C.; et al. Chemical Profile and Biological Effects of an Herbal Mixture for the Development of an Oil-in-Water Cream. Plants 2023, 12, 248. [Google Scholar] [CrossRef]
  40. Lloyd, J.U.; Lloyd, J.T. History of Hamamelis (Witch Hazel), Extract and Distillate. J. Am. Pharm. Assoc. 1935, 24, 220–224. [Google Scholar] [CrossRef]
  41. European Medicines Agency, Committee on Herbal Medicinal Products. EMA/HMPC/114583/2008 Corr. Community Herbal Monograph on Hamamelis Virginiana L., Cortex; European Medicines Agency, Committee on Herbal Medicinal Products: Amsterdam, The Netherlands, 2019. [Google Scholar]
  42. European Medicines Agency, Committee on Herbal Medicinal Products. EMA/HMPC/114584/2008. Community Herbal Monograph on Hamamelis Virginiana L., Folium et Cortex Aut Ramunculus Destillatum; European Medicines Agency, Committee on Herbal Medicinal Products: Amsterdam, The Netherlands, 2008. [Google Scholar]
  43. Hamamelidis Cortex (Hamamelis Bark)—ESCOP. Available online: https://www.escop.com/downloads/hamamelis-bark/ (accessed on 20 June 2025).
  44. Hamamelidis Folium (Hamamelis Leaf)—ESCOP. Available online: https://www.escop.com/downloads/hamamelis-leaf/ (accessed on 20 June 2025).
  45. Cheesman, M.J.; Alcorn, S.; Verma, V.; Cock, I.E. An Assessment of the Growth Inhibition Profiles of Hamamelis virginiana L. Extracts Against Streptococcus and Staphylococcus spp. J. Tradit. Complement. Med. 2021, 11, 457–465. [Google Scholar] [CrossRef]
  46. Cheesman, M.J.; Alcorn, S.R.; Cock, I.E. Effects of Hamamelis Virginiana L. Extracts on Pseudomonas Aeruginosa Growth and Antagonism of Ciprofloxacin. Pharmacogn. Commun. 2023, 13, 92–98. [Google Scholar] [CrossRef]
  47. Iauk, L.; Lo Bue, A.M.; Milazzo, I.; Rapisarda, A.; Blandino, G. Antibacterial Activity of Medicinal Plant Extracts against Periodontopathic Bacteria. Phytother. Res. 2003, 17, 599–604. [Google Scholar] [CrossRef]
  48. Kirsch, J.; Jung, A.; Hille, K.; König, B.; Hannig, C.; Kölling-Speer, I.; Speer, K.; Hannig, M. Effect of Fragaria Vesca, Hamamelis and Tormentil on the Initial Bacterial Colonization in Situ. Arch. Oral Biol. 2020, 118, 104853. [Google Scholar] [CrossRef]
  49. Santos, J.G.D.; Amêndola, I.; Bessa, E.R.L.; Back-Brito, G.N.; Oliveira, L.D.D. Effect of Hamamelis Virginiana, Persea Americana, Cynara Scolymus L and Stryphnodendron Barbatiman M Plant Extracts on the Phenotypic Expression of Virulence Factors in Biofilms of the Candida Albicans. Braz. Dent. Sci. 2024, 27, e4039. [Google Scholar] [CrossRef]
  50. Pereira, C.; Niranjan, P.; Manikantan, R. Clinical Isolates of Staphylococcus Aureus (R.): Biofilm Characterisation and Inhibitory Assay Using Hamamelis Virginiana (L.). Int. J. Pharm. Bio Sci. 2014, 5, 809–819. [Google Scholar]
  51. Rasooly, R.; Molnar, A.; Choi, H.-Y.; Do, P.; Racicot, K.; Apostolidis, E. In-Vitro Inhibition of Staphylococcal Pathogenesis by Witch-Hazel and Green Tea Extracts. Antibiotics 2019, 8, 244. [Google Scholar] [CrossRef] [PubMed]
  52. Rasooly, R.; Choi, H.-Y.; Do, P.; Morroni, G.; Brescini, L.; Cirioni, O.; Giacometti, A.; Apostolidis, E. whISOBAXTM Inhibits Bacterial Pathogenesis and Enhances the Effect of Antibiotics. Antibiotics 2020, 9, 264. [Google Scholar] [CrossRef] [PubMed]
  53. Rasooly, R.; Howard, A.C.; Balaban, N.; Hernlem, B.; Apostolidis, E. The Effect of Tannin-Rich Witch Hazel on Growth of Probiotic Lactobacillus Plantarum. Antibiotics 2022, 11, 395. [Google Scholar] [CrossRef]
  54. Failla, M.; Lee, J.; Rasooly, R.; Apostolidis, E. Evaluation of a Witch Hazel Extract for the Potential Prebiotic and Protective Effect on Select Lactiplantibacillus Plantarum (Prev. Lactobacillus Plantarum) Strains. Front. Nutr. 2022, 9, 874666. [Google Scholar] [CrossRef]
  55. Treviño-Garza, M.Z.; Yañez-Echeverría, S.A.; García, S.; Mora-Zúñiga, A.E.; Arévalo Niño, K.; Universidad Autónoma de Nuevo León. Physico-Mechanical, Barrier and Antimicrobial Properties of Linseed Mucilague Films Incorporated with H. Virginiana Extract. Rev. Mex. Ing. Quím. 2019, 19, 983–996. [Google Scholar] [CrossRef]
  56. Brantner, A.; Grein, E. Antibacterial Activity of Plant Extracts Used Externally in Traditional Medicine. J. Ethnopharmacol. 1994, 44, 35–40. [Google Scholar] [CrossRef]
  57. Dzabijeva, D.; Boroduske, A.; Ramata-Stunda, A.; Mazarova, N.; Nikolajeva, V.; Boroduskis, M.; Nakurte, I. Anti-Bacterial Activity and Online HPLC-DPPH Based Antiradical Kinetics of Medicinal Plant Extracts of High Relevance for Cosmetics Production. Key Eng. Mater. 2018, 762, 8–13. [Google Scholar] [CrossRef]
  58. Rasooly, R.; Molnar, A.; Do, P.; Morroni, G.; Brescini, L.; Cirioni, O.; Giacometti, A.; Apostolidis, E. Witch Hazel Significantly Improves the Efficacy of Commercially Available Teat Dips. Pathogens 2020, 9, 92. [Google Scholar] [CrossRef]
  59. Nardini, E.F.; Almeida, T.S.; Yoshimura, T.M.; Ribeiro, M.S.; Cardoso, R.J.; Garcez, A.S. The Potential of Commercially Available Phytotherapeutic Compounds as New Photosensitizers for Dental Antimicrobial PDT: A Photochemical and Photobiological in Vitro Study. Photodiagnosis Photodyn. Ther. 2019, 27, 248–254. [Google Scholar] [CrossRef] [PubMed]
  60. Solis-Arevalo, K.K.; Garza-Gonzalez, M.T.; Lopez-Calderon, H.D.; Solis-Rojas, C.; Arevalo-Nino, K. Electrospun Membranes Based on Schizophyllan-PVOH and Hamamelis Virginiana Extract: Antimicrobial Activity Against Microorganisms of Medical Importance. IEEE Trans. NanoBioscience 2019, 18, 522–527. [Google Scholar] [CrossRef] [PubMed]
  61. Molin, M.L.; Segat, B.; Garcia, M.C.F.; Pezzin, A.P.T.; Silveira, M.L.L.; Schneider, A.L.D.S. Development and Characterization of Bacterial Cellulose Membrane Incorporated with Witch Hazel Extract. Matér. Rio Jan. 2023, 28, e20230008. [Google Scholar] [CrossRef]
  62. Erdelmeier, C.; Cinatl, J.; Rabenau, H.; Doerr, H.; Biber, A.; Koch, E. Antiviral and Antiphlogistic Activities of Hamamelis Virginiana Bark. Planta Med. 1996, 62, 241–245. [Google Scholar] [CrossRef]
  63. Bedoya, L.M.; Palomino, S.S.; Abad, M.J.; Bermejo, P.; Alcami, J. Screening of Selected Plant Extracts for in Vitro Inhibitory Activity on Human Immunodeficiency Virus. Phytother. Res. 2002, 16, 550–554. [Google Scholar] [CrossRef]
  64. Piazza, S.; Martinelli, G.; Magnavacca, A.; Fumagalli, M.; Pozzoli, C.; Terno, M.; Canilli, L.; Angarano, M.; Maranta, N.; Dell’Agli, M.; et al. Unveiling the Ability of Witch Hazel (Hamamelis virginiana L.) Bark Extract to Impair Keratinocyte Inflammatory Cascade Typical of Atopic Eczema. Int. J. Mol. Sci. 2022, 23, 9279. [Google Scholar] [CrossRef]
  65. Hartisch, C.; Kolodziej, H.; Von Bruchhausen, F. Dual Inhibitory Activities of Tannins from Hamamelis Virginiana and Related Polyphenols on 5-Lipoxygenase and Lyso-PAF: Acetyl-CoA Acetyltransferase1. Planta Med. 1997, 63, 106–110. [Google Scholar] [CrossRef]
  66. Manville, R.W.; Yoshimura, R.F.; Yeromin, A.V.; Hogenkamp, D.; Van Der Horst, J.; Zavala, A.; Chinedu, S.; Arena, G.; Lasky, E.; Fisher, M.; et al. Polymodal K+ Channel Modulation Contributes to Dual Analgesic and Anti-Inflammatory Actions of Traditional Botanical Medicines. Commun. Biol. 2024, 7, 1059. [Google Scholar] [CrossRef]
  67. Liu, X.; Hage, T.; Chen, L.; Wang, E.H.C.; Liao, I.; Goldberg, J.; Gosto, S.; Cziryak, P.; Senna, M.; Chen, Y.; et al. Revealing the Therapeutic Potential: Investigating the Impact of a Novel Witch Hazel Formula on Anti-Inflammation and Antioxidation. J. Cosmet. Dermatol. 2025, 24, e16662. [Google Scholar] [CrossRef]
  68. Thring, T.S.; Hili, P.; Naughton, D.P. Antioxidant and Potential Anti-Inflammatory Activity of Extracts and Formulations of White Tea, Rose, and Witch Hazel on Primary Human Dermal Fibroblast Cells. J. Inflamm. 2011, 8, 27. [Google Scholar] [CrossRef]
  69. Fernandez-Guarino, M.; Naharro-Rodriguez, J.; Bacci, S. Aberrances of the Wound Healing Process: A Review. Cosmetics 2024, 11, 209. [Google Scholar] [CrossRef]
  70. Almadani, Y.H.; Vorstenbosch, J.; Davison, P.G.; Murphy, A.M. Wound Healing: A Comprehensive Review. Semin. Plast. Surg. 2021, 35, 141–144. [Google Scholar] [CrossRef] [PubMed]
  71. Patenall, B.L.; Carter, K.A.; Ramsey, M.R. Kick-Starting Wound Healing: A Review of Pro-Healing Drugs. Int. J. Mol. Sci. 2024, 25, 1304. [Google Scholar] [CrossRef]
  72. Dezena, R.M.B.; Ireno, A.B.; Silva, G.H.D. Employing Optical Microscopy Technique to Determine the Tissue Action of Hamamelis virginiana L. (Hamamelidaceae), Maytenus ilicifoliaMart. Ex Reissek (Celastraceae) and Casearia Sylvestris Sw. (Salicaceae) Tinctures on Skin-Fixed Histological Sections of Wistar Rats. Rev. Ciênc. Farm. Básica E Apl. RCFBA 2021, 42, e733. [Google Scholar] [CrossRef]
  73. Thring, T.S.; Hili, P.; Naughton, D.P. Anti-Collagenase, Anti-Elastase and Anti-Oxidant Activities of Extracts from 21 Plants. BMC Complement. Altern. Med. 2009, 9, 27. [Google Scholar] [CrossRef]
  74. Antonio, F.; Guillem, R.; Sonia, T.; Clara, M.; Piergiorgio, G.; Valeria, C.; Gianluca, C.; Tzanov, T. Cross-linked Collagen Sponges Loaded with Plant Polyphenols with Inhibitory Activity towards Chronic Wound Enzymes. Biotechnol. J. 2011, 6, 1208–1218. [Google Scholar] [CrossRef]
  75. Rocasalbas, G.; Francesko, A.; Touriño, S.; Fernández-Francos, X.; Guebitz, G.M.; Tzanov, T. Laccase-Assisted Formation of Bioactive Chitosan/Gelatin Hydrogel Stabilized with Plant Polyphenols. Carbohydr. Polym. 2013, 92, 989–996. [Google Scholar] [CrossRef]
  76. Ramos, M.F.S.; Santos, E.P.; Bizarri, C.H.B.; Mattos, H.A.; Padilha, M.R.S.; Duarte, H.M. Preliminary Studies towards Utilization of Various Plant Extracts as Antisolar Agents. Int. J. Cosmet. Sci. 1996, 18, 87–101. [Google Scholar] [CrossRef]
  77. Choi, J.; Yang, D.; Moon, M.Y.; Han, G.Y.; Chang, M.S.; Cha, J. The Protective Effect of Hamamelis Virginiana Stem and Leaf Extract on Fine Dust-Induced Damage on Human Keratinocytes. Cosmetics 2021, 8, 119. [Google Scholar] [CrossRef]
  78. Silva, A.P.D.; Rocha, R.; Silva, C.M.L.; Mira, L.; Duarte, M.F.; Florȇncio, M.H. Antioxidants in Medicinal Plant Extracts. A Research Study of the Antioxidant Capacity of Crataegus, Hamamelis and Hydrastis. Phytother. Res. 2000, 14, 612–616. [Google Scholar] [CrossRef]
  79. Masaki, H.; Sakaki, S.; Atsumi, T.; Sakurai, H. Active-Oxygen Scavenging Activity of Plant Extracts. Biol. Pharm. Bull. 1995, 18, 162–166. [Google Scholar] [CrossRef] [PubMed]
  80. Choi, H.R.; Choi, J.S.; Han, Y.N.; Bae, S.J.; Chung, H.Y. Peroxynitrite Scavenging Activity of Herb Extracts. Phytother. Res. 2002, 16, 364–367. [Google Scholar] [CrossRef] [PubMed]
  81. Pazos, M.; Torres, J.L.; Andersen, M.L.; Skibsted, L.H.; Medina, I. Galloylated Polyphenols Efficiently Reduce α-Tocopherol Radicals in a Phospholipid Model System Composed of Sodium Dodecyl Sulfate (SDS) Micelles. J. Agric. Food Chem. 2009, 57, 5042–5048. [Google Scholar] [CrossRef]
  82. Furger, C.; Gironde, C.; Rigal, M.; Dufour, C.; Guillemet, D. Cell-Based Antioxidant Properties and Synergistic Effects of Natural Plant and Algal Extracts Pre and Post Intestinal Barrier Transport. Antioxidants 2022, 11, 565. [Google Scholar] [CrossRef]
  83. Hughes-Formella, B.J.; Bohnsack, K.; Rippke, F.; Benner, G.; Rudolph, M.; Tausch, I.; Gassmueller, J. Anti-Inflammatory Effect of Hamamelis Lotion in a UVB Erythema Test. Dermatology 1998, 196, 316–322. [Google Scholar] [CrossRef]
  84. Hughes-Formella, B.J.; Filbry, A.; Gassmueller, J.; Rippke, F. Anti-Inflammatory Efficacy of Topical Preparations with 10% Hamamelis Distillate in a UV Erythema Test. Skin Pharmacol. Physiol. 2002, 15, 125–132. [Google Scholar] [CrossRef]
  85. Serper, A.; Ozbek, M.; Calt, S. Accidental Sodium Hypochlorite-Induced Skin Injury During Endodontic Treatment. J. Endod. 2004, 30, 180–181. [Google Scholar] [CrossRef]
  86. Wolff, H.H.; Kieser, M. Hamamelis in Children with Skin Disorders and Skin Injuries: Results of an Observational Study. Eur. J. Pediatr. 2007, 166, 943–948. [Google Scholar] [CrossRef]
  87. Veronese, F.; Esposto, E.; Airoldi, C.; Di Cristo, N.; Paganini, P.; Savoia, P.; Zavattaro, E. A Randomized Controlled Prospective Cohort Study on the Efficacy of a Witch Hazel Extract Cream for the Eyelids and Eye Contour Area and a Cleansing Face Cream in Dermatitis of the Eyelids. Cosmetics 2024, 11, 83. [Google Scholar] [CrossRef]
  88. Korting, H.C.; Schäfer-Korting, M.; Hart, H.; Laux, P.; Schmid, M. Anti-Inflammatory Activity of Hamamelis Distillate Applied Topically to the Skin: Influence of Vehicle and Dose. Eur. J. Clin. Pharmacol. 1993, 44, 315–318. [Google Scholar] [CrossRef]
  89. Korting, H.C.; Schäfer-Korting, M.; Klövekon, W.; Klövekorn, G.; Martin, C.; Laux, P. Comparative Efficacy of Hamamelis Distillate and Hydrocortisone Cream in Atopic Eczema. Eur. J. Clin. Pharmacol. 1995, 48, 461–465. [Google Scholar] [CrossRef] [PubMed]
  90. Natella, F.; Guantario, B.; Ambra, R.; Ranaldi, G.; Intorre, F.; Burki, C.; Canali, R. Human Metabolites of HamafortonTM (Hamamelis virginiana L. Extract) Modulates Fibroblast Extracellular Matrix Components in Response to UV-A Irradiation. Front. Pharmacol. 2021, 12, 747638. [Google Scholar] [CrossRef] [PubMed]
  91. Duwiejua, M.; Zeitlin, I.J.; Waterman, P.G.; Gray, A.I. Anti-Inflammatory Activity of Polygonum Bistorta, Guaiacum Officinale and Hamamelis Virginiana in Rats. J. Pharm. Pharmacol. 1994, 46, 286–290. [Google Scholar] [CrossRef]
  92. Jamshidi-Aidji, M.; Macho, J.; Mueller, M.B.; Morlock, G.E. Effect-Directed Profiling of Aqueous, Fermented Plant Preparations via High-Performance Thin-Layer Chromatography Combined with in Situ Assays and High-Resolution Mass Spectrometry. J. Liq. Chromatogr. Relat. Technol. 2019, 42, 266–273. [Google Scholar] [CrossRef]
  93. Masaki, H.; Atsumi, T.; Sakurai, H. Hamamelitannin as a New Potent Active Oxygen Scavenger. Phytochemistry 1994, 37, 337–343. [Google Scholar] [CrossRef]
  94. Masaki, H.; Atsumi, T.; Sakurai, H. Protective Activity of Hamamelitannin on Cell Damage Induced by Superoxide Anion Radicals in Murine Dermal Fibroblasts. Biol. Pharm. Bull. 1995, 18, 59–63. [Google Scholar] [CrossRef]
  95. Masaki, H.; Atsumi, T.; Sakurai, H. Protective Activity of Hamamelitannin on Cell Damage of Murine Skin Fibroblasts Induced by UVB Irradiation. J. Dermatol. Sci. 1995, 10, 25–34. [Google Scholar] [CrossRef]
  96. Masaki, H.; Atsumi, T.; Sakurai, H. Evaluation of Superoxide Scavenging Activities of Hamamelis Extract and Hamamelitannin. Free Radic. Res. Commun. 1993, 19, 333–340. [Google Scholar] [CrossRef]
  97. Bassyouni, R.; Dwedar, R.; Farahat, M.; Kamel, Z.; Elwekel, M. Protective Effect of Hamamelitannin against Biofilm Production by Methicillin-Resistant Staphylococci Isolated from Blood of Patients at Intensive Care Units. Br. Microbiol. Res. J. 2015, 10, 1–8. [Google Scholar] [CrossRef]
  98. Cobrado, L.; Silva-Dias, A.; Azevedo, M.M.; Pina-Vaz, C.; Rodrigues, A.G. In Vivo Antibiofilm Effect of Cerium, Chitosan and Hamamelitannin against Usual Agents of Catheter-Related Bloodstream Infections. J. Antimicrob. Chemother. 2013, 68, 126–130. [Google Scholar] [CrossRef]
  99. Witch Hazel (USP) Specification—American Distilling. Available online: https://www.americandistilling.com/witch-hazel-usp-specification/ (accessed on 20 June 2025).
  100. Rulemaking History for OTC Skin Protectant Drug Products|FDA. Available online: https://www.fda.gov/drugs/historical-status-otc-rulemakings/rulemaking-history-otc-skin-protectant-drug-products (accessed on 20 June 2025).
  101. CosIng—Cosmetics—GROWTH—European Commission. Available online: https://ec.europa.eu/growth/tools-databases/cosing/details/ (accessed on 20 June 2025).
  102. Japan Cosmetic Regulations—Global Regulatory Partners, Inc. Available online: https://globalregulatorypartners.com/resource-center/regulatory-intelligence-platform/japan-regulatory-intelligence/japan-cosmetic-regulations/ (accessed on 20 June 2025).
  103. The National Medical Products Administration. Available online: https://english.nmpa.gov.cn/aboutNMPA.html (accessed on 20 June 2025).
Figure 1. Photo of the H. virginiana plant and the parts of the plant used in the treatment of skin disorders. All photos come from the private collection of F. Graczyk and were taken at the Collegium Medicum’s Garden of Medicinal and Cosmetic Plants in Bydgoszcz, Nicolaus Copernicus University (Poland).
Figure 1. Photo of the H. virginiana plant and the parts of the plant used in the treatment of skin disorders. All photos come from the private collection of F. Graczyk and were taken at the Collegium Medicum’s Garden of Medicinal and Cosmetic Plants in Bydgoszcz, Nicolaus Copernicus University (Poland).
Molecules 30 02744 g001
Figure 2. Example of some representatives polyphenolic compounds identified in H. virginiana extracts.
Figure 2. Example of some representatives polyphenolic compounds identified in H. virginiana extracts.
Molecules 30 02744 g002
Figure 3. The main biological activities studied for H. virginiana extracts.
Figure 3. The main biological activities studied for H. virginiana extracts.
Molecules 30 02744 g003
Table 1. Chemical composition of Hamamelis virginiana L.
Table 1. Chemical composition of Hamamelis virginiana L.
Extraction Solvent, MethodPlant PartCompounds IdentifiedIdentificationRef
Water, maceration at 5 °CLeaves3-, 4- and 5 -caffeoylquinic acid, 3- and 5- p-coumaroylquinic acid, catechin, procyanidin trimer and dimer, gallic acid–quinic acid ester, caffeoylshikimic acid, quercetin (Q) and Q-galloyl hexoside, ellagic acid, Q- rutinoside, kaempferol (K) and K- hexoside, K- hexoside–deoxyhexoside, K-galloyl hexoside, mono-, hexa-, hepta- octa-, nona- and deca-galloyl hexose, HPLC-ESI-MS/MS[24]
Acetone–water (8:2), maceration at 5 °CLeaves3-, 4- and 5 -caffeoylquinic acid, quercetin–galloyl hexoside, quercetin rutinoside, kaempferol (K) and K- hexoside, K- hexoside–deoxyhexoside, K-galloyl hexoside,
quercetin, hexa-, hepta-, octa-, nona- and decagalloyl hexose
HPLC-ESI-MS/MS[24]
Glycol, no data on extraction methodTwigs and bark4-hydroxybenzoic acid, vanillin, vanillic acid, protocatechuic acid, methyl gallate, ferulic acid, ellagic acid, isorhamnetin-3-o-glucoside, quercetin-3-o-glucoside, naringenin, catechin, epicatechin, gallocatechin, epigallocatechin, hamamelitanninUPLC/QqQ-MS/MS[26]
Water, acetonitrile ethanol, acetone (15%), sonicationBark, twigs, leaveshamamelitannin, catechin, gallocatechin, gallic acidHPLC-UV[27]
60% ethanol in water, maceration and ultrafiltrationBark, leaveshamamelitannin, pentagalloylglucose, gallic acid, tannic acidLC (isolation)[32]
Purified hot water, heating at 90 °CLeaves1-o-galloyl-β-d-glucose, gallic acid, galloyl-hexose a, c, d, hamamelitannin, tetra-, penta-, hexa- hepta-, octa-, nona-, and deca-o-galloyl-hexoseUHPLC-MS qToF[28]
Maceration with acetone–water (7:3), fractionation from water Stemsflavanol (catechin) monomers, proanthocyanidins, hydrolyzable tannins: hamamelitannin, methyl gallate, pentagalloyl glucoseLC-MS-MS[33]
propylene glycol, macerationLeavesderivatives of gallic acidHPLC-DAD[25]
Isolation from polyvinylpyrrolidone/water Barkpolysaccharides and procyanidinsGPC, GC -MS[34]
Extraction with acetone–water (7:3); isolation from water Barkcatechin, tannins (hamamelitannin), proanthocyanidins1H-NMR, HPLC[35]
Extraction with acetone–water (7:3); isolation from water Barkpolymeric proanthocyanidins, epicatechin, epigallocatechinGPC, HPLC, TLC[36]
45 and 70% ethanol, isolation using ethyl acetate followed by LCLeaves and barkkaempferol, quercetin, trifolin, kaempferol-3-o-d-glucuronide, hyperin, quercituron/mikwelianin, caffeic, chlorogenic, gallic acids, hamamelitannin, cyanidine, delfinidineIdentification by melting point and UV-Vis spectra[37]
Water distillation (volatile fraction)Leaves and barkabout 175 (leaves) and 168 (bark) volatile compounds: homologous series of alkanes, alkenes, aliphatic alcohols, aldehydes, ketones, fatty acid estersGC-MS[30]
Water, macerationWhole plantgallic acid, hamamelitanninHPLC-DAD, FL[38]
50% ethanol in water, maceration under periodical stirringLeavescaffeic acid, carnosic acid, chlorogenic acid, ferulic acid, gallic acid, ellagic acid, salicylic acid, trans-p-coumaric acid, apigenin, catechin, chrysin, hyperoside, kaempferol, luteolin, luteolin-7-o-glucoside, myricetin, naringenin, pyrocatechol, quercetin, quercitrin, rutoside, vitexinLC-MS[39]
Water, methanol, ethyl acetate, hexane, chloroform, maceration under periodical stirringLeavesisobutyl ether, 3,5,5-trimethylhexanol, 2-ethyl-1-hexanol, 1-nonanol, menthol, 3-methoxy-3-methylbutanol, phthalane, nonanal, 2-ethyl-1-hexyl acetate, 2-heptyl-1,3-dioxolane, 5,6,7,8,9-octahydro-2h-benzo[a]cyclohepten-2-one, decanal, epoxy-cumene, 1,3-di-tert-butylbenzene, trans-2-decenal, camphene, 1,3-dioxolane-2-methanol, 2,2,4-trimethyl-1,3-pentanediol diisobutyrate, (e)-2-dodecen-1-al, 1,3-pentanediol, 2,2,4-trimethyl-, 1-isobutyrateGC-MS[31]
HPLC—high performance liquid chromatography; GC—gas chromatography; LC—liquid chromatography; DAD—UV-Vis detector; FL—fluorescence detector; MS—mass spectrometry; HPLC-ESI-MS/MS—high-performance liquid chromatography coupled with electrospray ionization tandem MS; UHPLC-MS-qToF—ultra-high-performance liquid chromatography coupled with MS using quadrupole time-of-flight; UPLC/QqQ-MS/MS—ultra-performance liquid chromatography coupled with triple quadrupole tandem MS; TLC—thin-layer chromatography; NMR—nuclear magnetic resonance; GPC—gel permeation chromatography.
Table 2. Antibacterial and antifungal activity of extracts from H. virginiana.
Table 2. Antibacterial and antifungal activity of extracts from H. virginiana.
Material/Extract/MethodAntibacterial/Antifungal EffectRef
Leaf/water (w),
methanol (m)
24 h of maceration with continuous mixing
MIC (µg/mL)
Escherichia coli 3448 (w); 1173 (m)
ESBL E. coli 1724 (w); 670 (m)
Staphylococcus aureus 493 (w); 251 (m)
MRSA 431 (w); 168 (m)
Klebsiella pneumoniae 1724 (w); 1341 (m)
ESBL K. pneumoniae 2463 (w); 1257 (m)
[31]
MIC (µg/mL)
Staphylococcus oralis 1478 (w); 838 (m)
Staphylococcus pyogenes 1724 (w); 503 (m)
Staphylococcus mutants 4925 (w) >10,000 (m)
Streptococcus epidermidis 308 (w); 210 (m)
Streptococcus aureus 493 (w); 251 (m)
[45]
Pseudomonas aeruginosa 1724 (w); 587 (m) µg/mL[46]
Leaf/propylene glycol
(no detail on method)
MIC/MFC (mg/mL)
Candida albicans 1.56/6.25,
Candida dubliniensis 0.78/3.12,
Candida glabrata 1.56/6.25,
Candida guilliermondii 0.39/3.12,
Candida krusei 0.19/3.12
Candida tropicalis 0.39/3.12.
[25]
MIC/MBC (mg/mL)
Acinetobacter baumannii 3.13/12.5,
Escherichia coli 12.5/25,
Klebsiella pneumoniae 12.5/12.5,
Enterococcus faecalis >50
Streptococcus aureus, S. mutans >50
[25]
Leaves/water 10% decoctionsMIC (mg/L)
Porphyromonas asaccharolityca 256
P. gingivalis (5) * 256, 1024, 1024, 8192, 16,384
Prevotella melaninogenica (2) * 256, 256
Prevotella intermedia 2048
Fusobacterium nucleatum ≥16,384
Capnocytophaga gingivalis 16,384
Veilonella parvula 4096
Eikenella corrodens 128
Peptostreptococcus micros (2) * 4096, 8192
Actinomyces odontolitycus (3) * 128, 256, 128
[47]
Leaves/methanol (Soxhlet)
MIC (mg/L)
Porphyromonas asaccharolityca 128
P. gingivalis (5) * 64, 256, 256, 512, 2048
Prevotella melaninogenica (2) * 64, 64
Prevotella intermedia 512
Fusobacterium nucleatum 16,384
Capnocytophaga gingivalis 4096
Veilonella parvula 2048
Eikenella corrodens 32
Peptostreptococcus micros (2) * 2048, 2048
Actinomyces odontolitycus (3) * 32, 128, 32
[47]
Leaves/50% ethanol (1:6) maceration for 10 days, decantation and filtrationZOI/MIC/MBC (mm/mg GAE/µL)
MSSA 19.17/0.2494/0.4988
MRSA 16.83/0.2494/0.4988
Bacillus cereus 18.17/0.2494/0.4988
Enterococcus faecalis 17.67/0.4988/0.4988
Salmonella enterica 10.83/0.4988/0.4988
Escherichia coli 8.5/0.4988/0.4988
Pseudomonas aeruginosa 0/-
[39]
Commercial ethanolic fluid extract (leaves; 152 mg mL−1)MIC (mg/mL)
Listeria monocytogenes 1.18
Staphylococcus aureus and S. typhi 2.37
Escherichia coli 2.37
[55]
whISOBAX
(commercial ethanolic bark extract)
MIC (µg/mL)
Staphylococcus epidermidis 26
Staphylococcus aureus 26–104
Enterococcus faecalis 39–52
Enterococcus faecium 19–52
Staphylococcus agalactiae 1250–6667
Staphylococcus pneumoniae 2500–6667
Acinetobacter baumannii 156–208
Klebsiella pneumoniae 312–833
Pseudomonas aeruginosa 1667–5000
Escherichia coli 1250–10,000
[52]
Leaves (l) and bark (b)/boiling water for 5 min
evaporation to dryness
ZOI/MIC (mg/mL)
Staphylococcus aureus 15–16.5/0.4–0.8 (l); 13.7–16/10 (b)
Enterococcus faecalis 12.2/0.3 (l); 13.8/10 (b)
Bacillus subtilis 12.5/1.1 (l); 12.7/10 (b)
Escherichia coli 16.5/0.4 (l); 11.0/10 (b)
[56]
No data/maceration with 50% ethanol and 6% glycerinStaphylococcus epidermis ZOI 18 mm
Propionibacterium acnes subsp. acnes ZOI 18 mm
Propionibacterium granulosum ZOI 17 mm
[57]
ESBLs—clinical isolates expressing extended-spectrum-lactamases; MRSA—methicillin-resistant Staphylococcus aureus; MSSA—methicillin-susceptible S. aureus; *—number of strains; MIC—minimum inhibitory concentration; ZOI—zone of inhibition; MBC—minimum bactericidal concentration; MFC—minimum fungicidal concentration; l—leaves; b—bark; w—water extract; m—methanol extract.
Table 3. Anti-inflammatory activity of H. virginiana extracts.
Table 3. Anti-inflammatory activity of H. virginiana extracts.
ExtractModelObserved EffectRef
Propylene glycol leaf
25, 50 and 100 mg/mL
Murine macrophages
stimulated with LPS
↓IL-1β
↓ TNF-α
[25]
Propylene glycol leaf
25, 50 and 100 mg/mL
Murine macrophagesNO ↑[25]
Bark glycolic extract
0.5–50 µg/mL
HaCaTs induced with TNF-α↓IL- 17C (IC50 1.53 µg/mL)
↓ MMP-9 (IC50 1.11 µg/mL)
↓ IL-8 (IC50 38.93 µg/mL)
[26,64]
Bark glycolic extract
0.5–50 µg/mL
HaCaTs induced with TNF-α/INF -γ↓ TSLP (4.33 µg/mL)
↓ IL-6 (IC50 2.70 µg/mL)
[64]
Bark glycolic extract 0.5-50 µg/mLHaCaTs induced with TNF-α/IL-4↓ IL-6 (IC50 2.70 µg/mL)
↓ IL-6 (IC50 = 21.30 µg/mL)
[64]
Bark glycolic extract 0.5-50 µg/mLHaCaTs induced with IL-4↓CCL26 (IC50 = 21.36 µg/mL)[64]
Bark glycolic extract 5-250 µg/mLHaCaTs infected with C. acnes↓ IL-6 (IC50: 136.90 µg/mL
↓ IL-8
No impact on NO
[26]
Dried herb/water distillate
Evaporated (25, 50, 100, µg)
Fibroblast induced with H2O2↓ IL-8
[68]
Proanthocyanidins from bark/60% ethanolMouse ear
treated with croton oil
↓ Inflammation[62]
LPS—lipopolysaccharide; HaCaTs—human keratinocytes; MMP—matrix metalloproteinase; IL—interleukine; TNF-α—tumor necrosis factor alpha; IFN-γ—interferon gamma; NO—nitric oxide; TSLP—thymic stromal lymphopoietin; CCL26—chemokine (C-C motif) ligand 26.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Wójciak, M.; Pacuła, W.; Sowa, I.; Feldo, M.; Graczyk, F.; Załuski, D. Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications. Molecules 2025, 30, 2744. https://doi.org/10.3390/molecules30132744

AMA Style

Wójciak M, Pacuła W, Sowa I, Feldo M, Graczyk F, Załuski D. Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications. Molecules. 2025; 30(13):2744. https://doi.org/10.3390/molecules30132744

Chicago/Turabian Style

Wójciak, Magdalena, Wiktoria Pacuła, Ireneusz Sowa, Marcin Feldo, Filip Graczyk, and Daniel Załuski. 2025. "Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications" Molecules 30, no. 13: 2744. https://doi.org/10.3390/molecules30132744

APA Style

Wójciak, M., Pacuła, W., Sowa, I., Feldo, M., Graczyk, F., & Załuski, D. (2025). Hamamelis virginiana L. in Skin Care: A Review of Its Pharmacological Properties and Cosmetological Applications. Molecules, 30(13), 2744. https://doi.org/10.3390/molecules30132744

Article Metrics

Back to TopTop